Health CanadaGeneral Alert
Important information regarding Ethyol (amifostine) and severe cutaneous reactions - Health Professional Advisory
Published: March 12, 2003Recall ID: 24457Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Important information regarding Ethyol (amifostine) and severe cutaneous reactions - Health Professional Advisory
Recalling Firm: Marketed health products
Product Description & Identification
Important information regarding Ethyol (amifostine) and severe cutaneous reactions - Health Professional Advisory
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24457 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/important-information-regarding-ethyol-amifostine-and-severe-cutaneous-reactions |
| Title | Important information regarding Ethyol (amifostine) and severe cutaneous reactions - Health Professional Advisory |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2003-03-12 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Important information regarding Ethyol (amifostine) and severe cutaneous reactions - Health Professional Advisory Check if your household is affected: https://therecallfile.com/recalls/important-information-regarding-ethyol-amifostine-and-severe-cutaneous/CANADA-24457
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordImportant information regarding Ethyol (amifostine) and severe cutaneous reactions - Health Professional Advisory